亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北帝鑫化工制造有限公司銷售總部  

醫藥原料及醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:蘇健
  • 電話:027-50483962
  • 郵件:1691710457@qq.com
  • 傳真:027-67880826
  • QQ:1691710457
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 咪唑原料廠家,價格從優,用途說明及價格
咪唑原料廠家,價格從優,用途說明及價格
單價 100.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 50000公斤起訂1公斤
品牌 帝鑫
包裝 25公斤/桶
含量 99%
保質期 24個月
過期 長期有效
更新 2014-11-12 08:53
 
詳細信息

咪唑
中文別稱:甘惡啉;間二氮茂;咪唑;1,3-二氨雜環戊二烯;1,3-二氮雜茂;1,3-二氮雜-2,4-環戊二烯
英文名稱:Imidazole
英文別名:Glyoxaline; Imidazole Glyoxaline; Imidazole, ULTROL Grade; 1,3-diazole; IMZ  咪唑結構簡式
分子式:C3H4N2
分子量:68.0773
CAS號:288-32-4
MDL號:MFCD00005183
EINECS號:206-019-2
RTECS號:NI3325000
BRN號:103853
PubChem號:24896072
外觀:白色或微黃色結晶
水分:<0.3%
咪唑的質量分數:≥99.5%
灼燒殘渣(以***鹽計):≤0.05%
熔點:88~91℃
©2025 湖北帝鑫化工制造有限公司銷售總部 版權所有   技術支持:化工網   訪問量:25601  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |